HomeADMA • NASDAQ
ADMA Biologics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 114.80M | 40.22% |
Operating expense | 26.22M | 51.65% |
Net income | 26.90M | 51.10% |
Net profit margin | 23.44 | 7.77% |
Earnings per share | — | — |
EBITDA | 36.85M | 53.96% |
Effective tax rate | 19.57% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.63M | 58.03% |
Total assets | 510.57M | 45.51% |
Total liabilities | 137.15M | -30.44% |
Total equity | 373.42M | — |
Shares outstanding | 238.73M | — |
Price to book | 12.23 | — |
Return on assets | 17.45% | — |
Return on capital | 19.67% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 26.90M | 51.10% |
Cash from operations | -19.68M | -787.06% |
Cash from investing | -4.72M | -99.83% |
Cash from financing | -7.13M | -392.54% |
Net change in cash | -31.52M | -423.01% |
Free cash flow | -31.31M | -257.00% |
Previous close
$19.20
Day range
$19.23 - $19.97
Year range
$8.91 - $25.67
Market cap
4.67B USD
Avg Volume
4.24M
P/E ratio
23.31
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
685
